https://www.dukehealth.org/clinical-trials/directory/pro00115964
HCMT/MM2401: Ph2 study of Selinexor... | Clinical Trials at Duke
If you choose take part in this study, you will receive the study drug selinexor, along with bispecific antibodies that you would... | View the details of this...
clinical trialsstudyselinexorduke